Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Biotech start-up Tridek-One focused on research and development of CD31 agonists to restore the immune balance, has closed a €16 million ($16. Click to read more.
Tridek-One Closes €16M Funding finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.